Corbus PharmaceuticalsCRBP
那斯達克 · USD
9.68
-0.58
(-5.65%)
收盤 12/12 04:59 (UTC+8)
盤後
9.96
+0.28
(+2.89%)
12/12 04:59 (UTC+8)
Corbus PharmaceuticalsCRBP
9.68
-0.58
(-5.65%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | 24,417 | 19,152 | - | - | - | - | - | 10,104 | 9,488 | 8,189 |
研發費用 | 20,860 | 15,187 | 15,642 | 8,787 | 10,808 | 6,865 | 5,761 | 6,980 | 6,551 | 4,249 |
推銷及管理費用 | 3,557 | 3,965 | 4,133 | 3,818 | 4,697 | 4,123 | 3,861 | 3,124 | 2,937 | 3,940 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -24,417 | -19,152 | -19,775 | -12,605 | -15,505 | -10,988 | -9,623 | -10,103 | -9,488 | -8,189 |
其他收入及費用 | 1,075 | 1,490 | 2,797 | 3,075 | 2,103 | 1,643 | 2,901 | 2,078 | -296 | 181 |
利息費用 | - | - | - | - | 381 | 652 | - | -2,928 | -1,948 | - |
稅前純益 | -23,342 | -17,662 | -16,978 | -9,530 | -13,783 | -9,997 | -6,899 | -8,021 | -10,053 | -8,784 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -23,342 | -17,662 | -16,978 | -9,530 | -13,783 | -9,997 | -6,899 | -8,021 | -10,053 | -8,784 |
基本每股稅後盈餘(元) | -1.90 | -1.44 | -1.39 | -0.78 | -1.15 | -0.90 | -0.83 | - | -2.27 | -2.05 |
稀釋每股稅後盈餘(元) | -1.90 | -1.44 | -1.39 | -0.76 | -1.17 | -0.92 | -0.83 | -1.79 | -2.25 | -2.03 |
基本平均股數(千股) | 12307.00 | 12240.00 | 12202.00 | 12179.00 | 12014.00 | 11053.00 | 8310.00 | - | 4423.00 | 4277.00 |
稀釋平均股數(千股) | 12307.00 | 12240.00 | 12202.00 | 12179.00 | 12014.00 | 11053.00 | 8310.00 | - | 4423.00 | 4277.00 |
還原基本每股稅後盈餘(元) | -1.90 | -1.44 | -1.39 | -0.78 | -1.15 | -0.90 | -0.83 | - | -2.27 | -2.05 |
還原稀釋每股稅後盈餘(元) | -1.90 | -1.44 | -1.39 | -0.76 | -1.17 | -0.92 | -0.83 | -1.79 | -2.25 | -2.03 |
還原基本平均股數(千股) | 12,307 | 12,240 | 12,202 | 12,179 | 12,014 | 11,053 | 8,310 | - | 4,423 | 4,277 |
還原稀釋平均股數(千股) | 12,307 | 12,240 | 12,202 | 12,179 | 12,014 | 11,053 | 8,310 | - | 4,423 | 4,277 |
EBITDA(千元) | -23,342 | -18,029 | -17,101 | -10,223 | -13,807 | -10,021 | -7,469 | -10,691 | -11,791 | -8,473 |